Founded in 1985, Mentor, Ohio-based STERIS plc (STE) develops, manufactures and markets infection prevention, decontamination, microbial reduction, and surgical and gastrointestinal support products and services. The company’s market capitalization currently stands at $24.5 billion and is expected to unveil its Q3 2026 earnings report soon. Ahead of this event, analysts anticipate STERIS to generate earnings of$2.53 per share, representing an increase of 9.1% from $2.32 per share reported in the same qu ...